- Filed
- Nov 10, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Nov 3, 2025 | 19M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 19.11M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 19.02M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 19.07M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 19.15M sh |
| Stock Repurchased | Q3 2025 · Sep 30, 2025 | $2.41M |
| Stock Repurchased | Q3 2025 · Sep 30, 2024 | $12.98M |
| Capex | Q3 2025 · Sep 30, 2025 | $1.92M |
| Capex | Q3 2025 · Sep 30, 2024 | $2.74M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | $24.29M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | −$2.03M |
| Long Term Debt | Q3 2025 · Sep 30, 2025 | $35M |
| Long Term Debt | Q3 2025 · Dec 31, 2024 | $35M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $65.12M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $56.09M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2024 | $62.75M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | $157.67M |
| Stockholders Equity | Q3 2025 · Jun 30, 2025 | $159.54M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | $229.54M |
| Stockholders Equity | Q3 2025 · Sep 30, 2024 | $234.33M |
| Stockholders Equity | Q3 2025 · Jun 30, 2024 | $237.05M |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | $240.27M |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $182.1M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $203.97M |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $256.51M |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $274.33M |
| Current Assets | Q3 2025 · Sep 30, 2025 | $193.64M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $201.36M |
| Total Assets | Q3 2025 · Sep 30, 2025 | $414.18M |
| Total Assets | Q3 2025 · Dec 31, 2024 | $503.86M |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$0.11 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$4.49 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | −$0.30 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | −$0.32 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$0.11 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$4.49 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | −$0.30 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | −$0.32 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $51.29M |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $159.89M |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $56.9M |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $169.62M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$2.13M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$85.49M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$5.8M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$6.18M |
| Operating Income | Q3 2025 · Sep 30, 2025 | $4.46M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$76.18M |
| Operating Income | Q3 2025 · Sep 30, 2024 | −$731K |
| Operating Income | Q3 2025 · Sep 30, 2024 | $1.29M |
| Revenue | Q3 2025 · Sep 30, 2025 | $94.3M |
| Revenue | Q3 2025 · Sep 30, 2025 | $295.83M |
| Revenue | Q3 2025 · Sep 30, 2024 | $102.53M |
| Revenue | Q3 2025 · Sep 30, 2024 | $324.43M |